Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial

Fig. 3

a Comparison of changes in the global left ventricular ejection fraction (LVEF) between the WJMSC group and the placebo group measured by two dimensional-echocardiograph before transplantation and at the 4-, 12- and 18-month follow-ups. b. The absolute changes in LVEF, LVESV and LVEDV between the WJMSC group and the placebo group at 18 months measured by ECG and analyzed by ANCOVA. T-bars show the standard errors ANCOVA analysis of covariance, ECG echocardiogram, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, WJMSC Wharton’s jelly-derived mesenchymal stem cells

Back to article page